نتایج جستجو برای: hepatic amyloidosis

تعداد نتایج: 104741  

2012
Sanjay M. Banypersad Ashutosh D. Wechalekar

S ystemic amyloidosis is a relatively rare multisystem disease caused by the deposition of misfolded protein in various tissues and organs. It may present to almost any specialty, and diagnosis is frequently delayed.1 Cardiac involvement is a leading cause of morbidity and mortality, especially in primary light chain (AL) amyloidosis and in both wild-type and hereditary transthyretin amyloidosi...

2014
Ridvan Mercan Berivan Bıtık Mehmet Engin Tezcan Arif Kaya Abdurrahman Tufan Mehmet Akif Ozturk Seminur Haznedaroglu Berna Goker

Background. Systemic amyloidosis is a potentially fatal condition, unless diagnosed and treated before development of irreversible organ damage. Demonstration of amyloid deposits within tissue biopsies is only definitive diagnostic method, which makes appropriate selection of biopsy site essential. Herein, we evaluated efficacy of minimally invasive minor salivary gland biopsy (MSGB) for the di...

2014
Sonia Jerzykowska Maciej Cymerys Lidia A. Gil Andrzej Balcerzak Danuta Pupek-Musialik Mieczysław A. Komarnicki

Primary amyloidosis (AL) is a rare variety of plasma cell dyscrasia, the diagnosis of which is often difficult to establish. Pathogenesis of amyloidosis involves extracellular deposition of insoluble protein fibrils in tissues, leading to insufficiency of affected organs. According to various sources, mean survival rate of patients with primary amyloidosis ranges from 12 to 24 months, making pr...

2015
Michael Lopez-Molina Ashok V. Shiani Kellee L. Oller

BACKGROUND Amyloidosis is a systemic disease known to affect a vast range of organs, including the liver, heart, and kidney. When infiltrating the liver, amyloidosis typically does not present with cirrhosis. Typical presentation includes hepatomegaly with some mild laboratory abnormalities. CASE REPORT A 72-year-old man presented with a 2-week history of worsening abdominal, scrotal, and ext...

2013
Jennifer H Pinney Colette J Smith Jessi B Taube Helen J Lachmann Christopher P Venner Simon D J Gibbs Jason Dungu Sanjay M Banypersad Ashutosh D Wechalekar Carol J Whelan Philip N Hawkins Julian D Gillmore

Epidemiological studies of systemic amyloidosis are scarce and the burden of disease in England has not previously been estimated. In 1999, the National Health Service commissioned the National Amyloidosis Centre (NAC) to provide a national clinical service for all patients with amyloidosis. Data for all individuals referred to the NAC is held on a comprehensive central database, and these were...

Journal: :European respiratory review : an official journal of the European Respiratory Society 2017
Paolo Milani Marco Basset Francesca Russo Andrea Foli Giovanni Palladini Giampaolo Merlini

Amyloidosis is a disorder caused by misfolding of autologous protein and its extracellular deposition as fibrils, resulting in vital organ dysfunction and eventually death. Pulmonary amyloidosis may be localised or part of systemic amyloidosis.Pulmonary interstitial amyloidosis is symptomatic only if the amyloid deposits severely affect gas exchange alveolar structure, thus resulting in serious...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید